20-Mar-2026
TipRanks (Fri, 20-Mar 7:25 AM ET)
Business Wire (Wed, 18-Mar 4:00 PM ET)
GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors
Business Wire (Tue, 17-Mar 9:00 AM ET)
Business Wire (Mon, 9-Mar 9:00 AM ET)
GE HealthCare to showcase AI and digital leadership at HIMSS 2026
Business Wire (Thu, 5-Mar 9:00 AM ET)
Business Wire (Thu, 19-Feb 9:00 AM ET)
Business Wire (Tue, 17-Feb 9:00 AM ET)
GE HealthCare announces cash dividend for first quarter of 2026
Business Wire (Thu, 12-Feb 6:11 PM ET)
GE HealthCare management to present at upcoming investor conferences
Business Wire (Thu, 12-Feb 7:30 AM ET)
Business Wire (Mon, 9-Feb 8:00 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of March 20, 2026, GEHC stock price declined to $69.65 with 4,255,859 million shares trading.
GEHC has a beta of 2.02, meaning it tends to be more sensitive to market movements. GEHC has a correlation of 0.67 to the broad based SPY ETF.
GEHC has a market cap of $31.73 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $6 billion in Revenue and $1.44 earnings per share. This beat revenue expectation by $99 million and exceeded earnings estimates by $.03.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, VO, QQQ, IVV.
GEHC has underperformed the market in the last year with a price return of -14.7% while the SPY ETF gained +16.6%. GEHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.9% and -6.2%, respectively, while the SPY returned -4.4% and -3.3%, respectively.
GEHC support price is $68.81 and resistance is $71.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.